Status:
UNKNOWN
The JUMPSTART Program: Encouraging Early Mobilization and Optimizing Recovery of TAVR Patients' Post-hospital Discharge
Lead Sponsor:
Hamilton Health Sciences Corporation
Collaborating Sponsors:
Edwards Lifesciences
McMaster University
Conditions:
Aortic Valve Stenosis
Transcatheter Aortic Valve Replacement
Eligibility:
All Genders
Brief Summary
A virtual, self-directed, and tailored early mobilization program called JUMPSTART, that aims to bridge cardiac rehabilitation intake for post-TAVR patients has been developed at the Hamilton General ...
Detailed Description
Post-TAVR patients who have successfully completed a pre-discharge ambulation assessment and are deemed eligible for discharge will be eligible to participate. Potential participants will be introduce...
Eligibility Criteria
Inclusion
- Outpatients who have undergone a TAVR procedure at the Hamilton General Hospital
- Patients who are managed through the overnight-model pathway
- Patients who successfully completed ambulation assessment
- Patients who are deemed eligible for discharge
Exclusion
- Patients who are hospitalized after the procedure (inpatients)
- Patients who had an axillary approach for TAVR
- Patients who had a pacemaker temporarily left in at the end of case, and
- Patients who received a permanent pacemaker in the last month
Key Trial Info
Start Date :
March 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2024
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06040398
Start Date
March 1 2023
End Date
March 31 2024
Last Update
September 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hamilton Health Sciences (McMaster Children's Hospital and Hamilton General Hospital)
Hamilton, Ontario, Canada